ArticleThe FEBS journal2025

The G protein-coupled receptor GPR89A is a novel potential therapeutic target to overcome cisplatin resistance in NSCLC Calu1 cells.

Hale Guler Kara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.